Drugs / MTBVAC
Trials 9
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 12 trials | ||||||
| Phase 1 | NCT06438978 | Jan 2024 | tuberculosis | Bharat Biotech International Limited | Completed | No outcome recorded |
| Phase 1 | NCT02013245 | Jan 2013 → Jun 2014 | tuberculosis | Biofabri, S.L | Completed | No outcome recorded |
| Phase 1/22 trials | ||||||
| Phase 1/2 | NCT02933281 | May 2018 → Sep 2021 | tuberculosis | International AIDS Vaccine Initiative | Completed | No outcome recorded |
| Phase 1/2 | NCT02729571 | Sep 2015 → Sep 2016 | tuberculosis | Biofabri, S.L | Completed | No outcome recorded |
| Phase 24 trials | ||||||
| Phase 2 | NCT06997367 | Mar → Sep 2025 overdue | tuberculosis | Bharat Biotech International Limited | Active not recruiting | No outcome recorded |
| Phase 2 | NCT06272812 | Feb 2025 → Mar 2028 expected | tuberculosis | International AIDS Vaccine Initiative | Recruiting | No outcome recorded |
| Phase 2 | NCT05947890 | Jan 2024 → Apr 2027 expected | HIV infectious disease, tuberculosis | HIV Vaccine Trials Network | Recruiting | No outcome recorded |
| Phase 2 | NCT03536117 | Feb 2019 → May 2022 | tuberculosis | Biofabri, S.L | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT04975178 | Oct 2022 → Feb 2029 expected | tuberculosis | Biofabri, S.L | Recruiting | No outcome recorded |
Press releases naming this drug 4 releases
| Date | Issuer | Release |
|---|---|---|
| 2026-06-05 | Biofabri, S.L | The international consortium, MTBVAC AVANTE, officially launches its four-year program funded by Global Health EDCTP3. biofabri.es ↗ |
| 2025-12-22 | Bharat Biotech International Limited | Biofabri and Bharat Biotech sign technology transfer agreement to advance global access to MTBVAC and support tuberculosis control efforts. bharatbiotech.com ↗ |
| 2024-03-24 | Bharat Biotech International Limited | MTBVAC, the first vaccine against Tuberculosis derived from a human source, begins clinical trials in adults in India bharatbiotech.com ↗ |
| 2022-03-16 | Bharat Biotech International Limited | Bharat Biotech and Biofabri partner to develop, manufacture and distribute a novel TB vaccine, MTBVAC bharatbiotech.com ↗ |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 10 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MTBVAC | “Live, attenuated Mycobacterium tuberculosis (M. tb)- MTBVAC (MTBVAC)01 strain” NCT06438978 ↗ |
| Modality | Vaccine | “MTBVAC is a new live tuberculosis vaccine” PMID 26598141 ↗ Nov 2015 |
| Route | Other | “administered intradermally on Study Day 0” NCT02933281 ↗ |